Showing results (1-10 of 5,139) with videos related to
Sort By:
Pageof 514
Novartis Foundation Symposium|February 9, 1999
Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosisB Johnson, L G Bekker, S Ress, et al.Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 1997
rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placeboB J Johnson, L G Bekker, R Rickman, et al.The Journal of Infectious Diseases|August 11, 1998
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosisL G Bekker, G Maartens, L Steyn, et al.The Journal of Infectious Diseases|March 18, 2000
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosisL G Bekker, P Haslett, G Maartens, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathwaysL G Bekker, S Freeman, P J Murray, et al.Infection and Immunity|November 18, 2000
Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependentL G Bekker, A L Moreira, A Bergtold, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 30, 2017
Investigation of adult immunodeficiency and indications for immunoglobulin replacement therapyS RessOral Diseases|August 8, 2002
The epidemiology and pathophysiology of HIV--as seen by a South AfricanL G BekkerInfection and Immunity|May 29, 1998
Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patientsB J Johnson, I Estrada, Z Shen, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 6, 2014
Isoniazid preventive therapy for tuberculosis in South Africa: an assessment of the local evidence baseR Wood, L-G BekkerPageof 514